CoChat

Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis

Open access
Ye, Guiwen, Xie, Zhongyu, Zeng, Huiqiong, Wang, Peng, Li, Jinteng, Zheng, Guan, Wang, Shan, Cao, Qian, Li, Ming, Liu, Wenjie, Cen, Shuizhong, Li, Zhaofeng, Wu, Yanfeng, Ye, Zhizhong, Shen, Huiyong · 2020 · Cell Death & Disease

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

Ankylosing spondylitis (AS) is a chronic inflammatory disease possessing a morbid serum microenvironment with enhanced oxidative stress. Long-term exposure to an oxidative environment usually results in cellular senescence alone with cellular dysfunction. Mesenchymal stem cells (MSCs) are a kind of stem cell possessing strong capabilities for immunoregulation, and senescent MSCs may increase inflammation and participate in AS pathogenesis. The objective of this study was to explore whether and how the oxidative serum environment of AS induces MSC senescence. Here, we found that AS serum facilitated senescence of MSCs in vitro, and articular tissues from AS patients exhibited higher expression levels of the cell cycle arrest-related proteins p53, p21 and p16. Importantly, the levels of advanced oxidative protein products (AOPPs), markers of oxidative stress, were increased in AS serum and positively correlated with the extent of MSC senescence induced by AS serum. Furthermore, MSCs cultured with AS serum showed decreased mitochondrial membrane potential and ATP production together with a reduced oxygen consumption rate. Finally, we discovered that AS serum-induced mitochondrial dysfunction resulted in elevated reactive oxygen species (ROS) in MSCs, and ROS inhibition successfully rescued MSCs from senescence. In conclusion, our data demonstrated that the oxidative serum environment of AS facilitated MSC senescence through inducing mitochondrial dysfunction and excessive ROS production. These results may help elucidate the pathogenesis of AS and provide potential targets for AS treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-020-02993-x

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Compared with HD serum, AS serum facilitated MSCs senescence. a MSCs treated with AS serum displayed stronger SA-β-gal staining (black arrow) than those treated with HD serum (scale bar = 50 µm). b The percentages of SA-β-gal-positive cells among treated MSCs were 38.23 ± 7.47% and 15.66 ± 5.16% for AS serum and HD serum, respectively; n = 20, p < 0.001. c, d The expression of the cell cycle arrest-related proteins p53, p21, and p16 was detected by Western blotting, and the levels were higher in MSCs treated with AS serum than in those treated with HD serum. e The signal for p-H2A.X measured by immunofluorescence was more obvious in MSCs treated with AS serum than in those treated with HD serum (scale bar = 10 µm). The results are presented as the means ± SD (n = 20, determined by independent-sample t tests). All experiments were performed three independent times, *p < 0.05, **p < 0.01.
Fig. 1 Compared with HD serum, AS serum facilitated MSCs senescence. a MSCs treated with AS serum displayed stronger SA-β-gal staining (black arrow) than those treated with HD serum (scale bar = 50 µm). b The percentages of SA-β-gal-positive cells among treated MSCs were 38.23 ± 7.47% and 15.66 ± 5.16% for AS serum and HD serum, respectively; n = 20, p < 0.001. c, d The expression of the cell cycle arrest-related proteins p53, p21, and p16 was detected by Western blotting, and the levels were higher in MSCs treated with AS serum than in those treated with HD serum. e The signal for p-H2A.X measured by immunofluorescence was more obvious in MSCs treated with AS serum than in those treated with HD serum (scale bar = 10 µm). The results are presented as the means ± SD (n = 20, determined by independent-sample t tests). All experiments were performed three independent times, *p < 0.05, **p < 0.01.CC BY · PubMed Central
Fig. 2 MSCs located in the articular soft tissue of AS patients displayed remarkable characteristics of senescence. a Tissues from AS patients displayed stronger SA-β-gal staining (black arrow) than those from non-AS donors (scale bar = 100 µm). b–d Immunofluorescence detection indicated increased levels of p53 (b), p21 (c), and p16 (d) in MSCs in articular soft tissue samples from AS patients than in those from non-AS patients (scale bar = 40 µm). All experiments were performed three independent times (n = 4).
Fig. 2 MSCs located in the articular soft tissue of AS patients displayed remarkable characteristics of senescence. a Tissues from AS patients displayed stronger SA-β-gal staining (black arrow) than those from non-AS donors (scale bar = 100 µm). b–d Immunofluorescence detection indicated increased levels of p53 (b), p21 (c), and p16 (d) in MSCs in articular soft tissue samples from AS patients than in those from non-AS patients (scale bar = 40 µm). All experiments were performed three independent times (n = 4).CC BY · PubMed Central
Fig. 3 AS serum contained elevated AOPPs levels and could stimulate ROS production in MSCs. a The levels of AOPPs were higher in AS serum (108.0 ± 11.69 µmol/L) than in HD serum (44.63 ± 9.41 µmol/L); p < 0.001, n = 20. b–e The levels of AOPPs in AS serum were positively correlated with the level of CRP (r = 0.6055, p < 0.01) (b), BASDAI scores (r = 0.5635, p < 0.01) (c), the percentage of SA-β-gal-positive cells after treatment with AS serum (r = 0.7148, p < 0.01) (d), and the expression of the protein p53 in MSCs treated with AS serum (r = 0.65458, p < 0.01) (e–g). Flow cytometry detection revealed that the total ROS level was enhanced in MSCs treated with AS serum compared with those treated with HD serum. h AS serum-treated MSCs displayed a stronger signal for ROS than HD serum-treated MSCs under a fluorescence microscope (scale bar = 20 µm). The results in a, f, and g are presented as the means ± SD (n = 20, determined by independent-sample t tests). The data in b–e were determined by Pearson correlation and linear regression analysis (n = 20). All experiments were performed three independent times, *p < 0.05, **p < 0.01.
Fig. 3 AS serum contained elevated AOPPs levels and could stimulate ROS production in MSCs. a The levels of AOPPs were higher in AS serum (108.0 ± 11.69 µmol/L) than in HD serum (44.63 ± 9.41 µmol/L); p < 0.001, n = 20. b–e The levels of AOPPs in AS serum were positively correlated with the level of CRP (r = 0.6055, p < 0.01) (b), BASDAI scores (r = 0.5635, p < 0.01) (c), the percentage of SA-β-gal-positive cells after treatment with AS serum (r = 0.7148, p < 0.01) (d), and the expression of the protein p53 in MSCs treated with AS serum (r = 0.65458, p < 0.01) (e–g). Flow cytometry detection revealed that the total ROS level was enhanced in MSCs treated with AS serum compared with those treated with HD serum. h AS serum-treated MSCs displayed a stronger signal for ROS than HD serum-treated MSCs under a fluorescence microscope (scale bar = 20 µm). The results in a, f, and g are presented as the means ± SD (n = 20, determined by independent-sample t tests). The data in b–e were determined by Pearson correlation and linear regression analysis (n = 20). All experiments were performed three independent times, *p < 0.05, **p < 0.01.CC BY · PubMed Central
Fig. 4 ROS inhibition via NAC rescued MSCs from the senescence caused by AS serum. a, b NAC reduced the ROS level in AS serum-treated MSCs to the level in HD serum-treated MSCs. c, d NAC rescued the extent of SA-β-gal staining of MSCs (black arrow) induced by AS serum (scale bar = 50 µm). e, f NAC decreased the expression levels of the cell cycle arrest-related proteins p53, p21, and p16 in AS serum-treated MSCs to the levels in HD serum-treated MSCs. The results are presented as the means ± SD (n = 10, determined by independent-sample t tests). All experiments were performed three independent times, *p < 0.05, **p < 0.01.
Fig. 4 ROS inhibition via NAC rescued MSCs from the senescence caused by AS serum. a, b NAC reduced the ROS level in AS serum-treated MSCs to the level in HD serum-treated MSCs. c, d NAC rescued the extent of SA-β-gal staining of MSCs (black arrow) induced by AS serum (scale bar = 50 µm). e, f NAC decreased the expression levels of the cell cycle arrest-related proteins p53, p21, and p16 in AS serum-treated MSCs to the levels in HD serum-treated MSCs. The results are presented as the means ± SD (n = 10, determined by independent-sample t tests). All experiments were performed three independent times, *p < 0.05, **p < 0.01.CC BY · PubMed Central
Fig. 5 AS serum-mediated mitochondrial dysfunction in MSCs. a The mitochondrial membrane potential detected by the probe JC-1 showed reduced fluorescence of JC-1 polymers and elevated fluorescence of JC-1 monomers in MSCs treated with AS serum, which represented a reduced ∆Ψm in the AS serum-treated MSCs (scale bar = 10 µm). b The fluorescence index analyzed by ImageJ showed that the ratio of JC-1 monomers (green) to polymers (red) was higher in MSCs treated with AS serum than in those treated with HD serum, which implied a reduced ∆Ψm in the AS serum-treated MSCs. c ATP detection showed that AS serum treatment obviously reduced the ATP production of MSCs. d, e Mitochondrial oxygen consumption rate detection revealed that compared to HD serum, AS serum impaired the basal respiration, spare respiration and ATP production of MSCs. The results are presented as the means ± SD (n = 10, determined by independent-sample t tests). All experiments were performed three independent times, *p < 0.05, **p < 0.01.
Fig. 5 AS serum-mediated mitochondrial dysfunction in MSCs. a The mitochondrial membrane potential detected by the probe JC-1 showed reduced fluorescence of JC-1 polymers and elevated fluorescence of JC-1 monomers in MSCs treated with AS serum, which represented a reduced ∆Ψm in the AS serum-treated MSCs (scale bar = 10 µm). b The fluorescence index analyzed by ImageJ showed that the ratio of JC-1 monomers (green) to polymers (red) was higher in MSCs treated with AS serum than in those treated with HD serum, which implied a reduced ∆Ψm in the AS serum-treated MSCs. c ATP detection showed that AS serum treatment obviously reduced the ATP production of MSCs. d, e Mitochondrial oxygen consumption rate detection revealed that compared to HD serum, AS serum impaired the basal respiration, spare respiration and ATP production of MSCs. The results are presented as the means ± SD (n = 10, determined by independent-sample t tests). All experiments were performed three independent times, *p < 0.05, **p < 0.01.CC BY · PubMed Central
Fig. 6 Mitoquinone decreased the ROS level and reversed the senescence of MSCs caused by AS serum. a Mitochondrial ROS evaluation with MitoSOX showed that AS serum increased the mitochondrial ROS levels of MSCs and that MQ pretreatment eliminated this effect (scale bar = 40 µm). b, c The total ROS level detected by the probe DCFH-DA showed that MQ reduced the total ROS level of AS serum-treated MSCs to the level of HD serum-treated MSCs. d, e The SA-β-gal staining assay indicated that MQ decreased the percentage of SA-β-gal-positive MSCs (black arrow) treated with AS serum (scale bar = 50 µm). f, g Western blot analysis revealed that MQ reversed the expression of the cell cycle arrest-related proteins p53, p21, and p16 in MSCs treated with AS serum. The results are presented as the means ± SD (n = 10, determined by independent-sample t tests). All experiments were performed three independent times, *p < 0.05, **p < 0.01.
Fig. 6 Mitoquinone decreased the ROS level and reversed the senescence of MSCs caused by AS serum. a Mitochondrial ROS evaluation with MitoSOX showed that AS serum increased the mitochondrial ROS levels of MSCs and that MQ pretreatment eliminated this effect (scale bar = 40 µm). b, c The total ROS level detected by the probe DCFH-DA showed that MQ reduced the total ROS level of AS serum-treated MSCs to the level of HD serum-treated MSCs. d, e The SA-β-gal staining assay indicated that MQ decreased the percentage of SA-β-gal-positive MSCs (black arrow) treated with AS serum (scale bar = 50 µm). f, g Western blot analysis revealed that MQ reversed the expression of the cell cycle arrest-related proteins p53, p21, and p16 in MSCs treated with AS serum. The results are presented as the means ± SD (n = 10, determined by independent-sample t tests). All experiments were performed three independent times, *p < 0.05, **p < 0.01.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 66 references

Cited by

See all 115

Metadata

Authors
Ye, G., Xie, Z., Zeng, H., Wang, P., Li, J., Zheng, G., Wang, S., Cao, Q., Li, M., Liu, W., Cen, S., Li, Z., Wu, Y., Ye, Z., & Shen, H.
Affiliations
Sun Yat-sen University (CN)
Corresponding author
  • Wu, Yanfeng
  • Ye, Zhizhong
  • Shen, Huiyong
Venue
Cell Death & Disease
Published
2020-09-17
Volume
11
Issue
9
Pages
775-775
ISSN
2041-4889 (ISSN-L)
OpenAlex
W3087134616
Cited by
115
References
66
Citations by year
2026: 10 · 2025: 21 · 2024: 32 · 2023: 23 · 2022: 17 · 2021: 12
FWCI
7.81
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81971518, 81700884)
  • Fundamental Research Funds for the Central Universities (19ykpy01)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
Keywords
ankylosing spondylitis, mesenchymal stem cells, cellular senescence, oxidative stress, mitochondrial dysfunction, reactive oxygen species, advanced oxidation protein products, p53, p21, p16, mitochondrial membrane potential, ATP production, articular tissues
MeSH terms
Adenosine Triphosphate, Adult, Cell Cycle, Female, Humans, Inflammation, Male, Mitochondria, Organophosphorus Compounds, Oxygen, Oxygen Consumption, Spondylitis, Ankylosing, Stem Cells, Ubiquinone, Signal Transduction, Cytokines, Cellular Senescence, Reactive Oxygen Species, Oxidative Stress, Cell Proliferation, Membrane Potential, Mitochondrial, Young Adult, Cell Cycle Checkpoints, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis. https://app.cochat.ai/papers/10.1038/s41419-020-02993-x
The paper
Ye, G., Xie, Z., Zeng, H., Wang, P., Li, J., Zheng, G., Wang, S., Cao, Q., Li, M., Liu, W., Cen, S., Li, Z., Wu, Y., Ye, Z., & Shen, H. (2020). Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis. Cell Death & Disease. https://doi.org/10.1038/s41419-020-02993-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.